Description
Maternal Cardiac Arrest (MCA) is a life-threatening event that may occur in any healthcare setting, even outside the hospital. Cardiac arrest in this population poses unique challenges to a healthcare team since there are critical actions affecting two patients. The ALS: Maternal Cardiac Arrest Module explores the why of MCA and how to treat pregnant cardiac arrest patients within a hospital.
This eLearning course features True Adaptive™ learning, where students follow a learning path personalized by their own inputs and self-reported confidence level.
After successfully completing this course, students should be able to:
• Identify current factors influencing maternal morbidity and mortality in the United States in relation to maternal cardiac arrest
• Describe how to determine a different diagnosis for maternal cardiac arrest
• Describe the relevant physiologic changes of pregnancy that impact the resuscitation of Mother and Fetus during maternal cardiac arrest
• Discuss modifications that are required in maternal resuscitation protocols
• Describe key components of the management schema for response to cardiopulmonary arrest during pregnancy
• Discuss implementation strategies for ongoing resuscitation measures when initial resuscitation strategies are unsuccessful to achieve ROSC
Continuing Education Information
Advanced Life Support: Maternal Cardiac Arrest; Enduring Web Course
Original Release Date: 10/19/2022
Last Review Date: August 2022
Termination Date: 10/18/2025
Description
Maternal cardiac arrest (MCA) is a catastrophic event that may occur in any healthcare setting or even outside the hospital. Cardiac arrest in this population poses unique challenges to a healthcare team because there are 2 patients. This module will further explore the why of MCA and how to treat the pregnant cardiac arrest patient within a hospital.
Learning Objectives
At the conclusion, participants should be able to:
-
Identify current factors influencing maternal morbidity and mortality in the United States in relation to maternal cardiac arrest
-
Describe how to determine a differential diagnosis for maternal cardiac arrest
-
Describe the relevant physiologic changes of pregnancy that impact the resuscitation of mother and fetus during maternal cardiac arrest
-
Discuss modifications that are required in maternal resuscitation protocols
-
Describe key components of the management schema for response to cardiopulmonary arrest during pregnancy
-
Discuss implementation strategies for ongoing resuscitation measures when initial resuscitation strategies are unsuccessful to achieve return of spontaneous circulation
Accreditation Terms
Joint Accreditation: 10/19/2022 - 10/18/2025
CAPCE: 10/19/2022 - 10/18/2025
AARC: N/A
Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Heart Association designates this activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation and Successful Completion
Successful completion of this CE activity includes the following:
-
Complete all portions of the online course
-
Complete the course evaluation
-
Print the Certificate/Statement of Credit
Disclosure Statement
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.
The following authors/faculty have declared NO financial interest(s) and/or affiliations (check for not conflicts):
Jose G. Cabanas, MD, MPH
Sallie Johnson, PharmD, BCPS
Michael C. Kurz, MD, PhD
Kenneth Navarro, MEd, LP
Comilla Sasson, MD, PhD
Elizabeth Sinz, MD, MEd
Carolyn M. Zelop, MD
Amber Hoover, RN, MSN
The list represents the relationships that may be perceived as actual or reasonable conflicts of interest as reported on the Disclosure Questionnaire, which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 24-month period preceding the time that the individual is being asked to assume a role controlling content:
N/A
Target Audiences
- Physicians
- Nurse Practitioners
- Physician Assistants
- Nurses
- EMS: Paramedics
ADA Statement
The American Heart Association and American Stroke Association strive to make our websites accessible. The American Heart Association and American Stroke Association are committed to diversity, inclusion, and meeting the needs of all our constituents, including those with disabilities. We are continually improving our digital assets to comply with the accessibility guidelines for levels A and AA in accordance with WCAG 2.1.
If the format of any material on our web pages interferes with your ability to access the information, please contact us to request assistance or if you have questions or comments about our web sites’ accessibility.
Please call 1-800-AHA-USA-1 (1-800-242-8721) or submit an inquiry.